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Table. Primary outcomes of claudicant patients undergoing infrainguinal
bypass by smoking status
Outcomes
Smokers
(n ¼ 119), %
Nonsmokers
(n ¼ 91), % c2 P
Adjusted OR
(95% CI) P
MALE 21 11 .04 2.8 (1.1-7.4) .03
AFS 12 12 .91 1.2 (0.4-3.2) .8
Death 3 11 .03 0.3 (0.08-1.23) .09
Limb loss 10 1 .008 21.0 (1.5-292) .02
AFS, Amputation-free survival; CI, conﬁdence interval; MALE, major
adverse limb event; OR, odds ratio.
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Volume 60, Number 6 Abstracts 1715used to treat the endoleak in such patients, and the current series reports the
outcome of therapy in the Aneurysm Treatment Using the Heli-FX
EndoAnchor System Global Registry (ANCHOR).
Methods: During a 29-month period ending in July 2014, 201 pa-
tients were enrolled in ANCHOR and treated with EndoAnchors for imme-
diate type Ia endoleaks after endograft deployment (primary arm; n ¼ 109
[54.2%]) or type Ia endoleaks remote from EVAR (revision arm; n ¼ 92
[45.8%]). Patients were followed up for clinical outcomes over a mean of
15 6 6 months after EndoAnchor implantation. Computed tomography
(CT) images were reviewed by an independent core laboratory in 145 pa-
tients (72.1%) preoperatively and in 109 (54.2%) postoperatively (108
with contrast). Continuous variables were assessed with the Student t-test
and dichotomous variables with the Fisher exact test. Bonferroni corrections
were used for multiple comparisons.
Results: Aneurysms averaged 60 6 16 mm in maximum diameter,
with infrarenal neck length of 16 6 12 mm, infrarenal neck diameter of
28 6 6 mm, and infrarenal angulation of 37 6 17. Aortic necks were
<10 mm in length in 42.7% and <5 mm in 17.5% of patients. An average
of 6 6 2 and 7 6 3 EndoAnchors was implanted in the primary and revision
cases, respectively (P ¼ .003), with successful deployment and absence of
type Ia endoleak on completion angiography in 190 of 201 patients
(94.5%). Over mean follow-up of 15 6 6 months, all-cause mortality was
two of 200 (1.0%), with aneurysm-related reinterventions in 21 patients
(10.4%). There were 12 patients (6.0%) with endograft-related reinterven-
tions and 11 patients (5.5%) with EndoAnchor-related reinterventions, all
for type Ia endoleaks. There were no ruptures or open surgical conversions.
Core laboratory analysis identiﬁed endoleaks in 14 of 108 patients (13.0%)
with postoperative contrast CT studies; four of 60 in primary cases (6.7%),
and 10 of 48 in revisions (20.8%; P ¼ .043). The endoleak was evident on
the ﬁrst postoperative CT scan in all but one of these cases. Short neck pre-
dicted EndoAnchor failure; 18 6 13 mm vs 8 6 5 mm in those with and
without postoperative type Ia endoleaks, respectively (P < .001). Neck
length of 5 mm was evident in 39.1% of patients with 12-month CT scans;
sac enlargement (>5 mm) developed in 3.7% of patients.
Conclusions: EndoAnchors are successful in remediating type Ia
endoleaks in 87.0% of cases. Success was more frequent in patients treated
for endoleaks that were detected and treated at the time of the initial
EVAR compared with those identiﬁed and treated in follow-up. EndoAn-
chors should be considered as a potentially effective treatment option
when type Ia endoleak is encountered during or after EVAR.
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Aptus; K. Ouriel: Consultant, Aptus; Other, Aptus. M. Mehta: None; F.
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Introduction: Smoking cessation is one of the primary methods of
treating claudication. However, many patients receive revascularization for
claudication while still smoking. We examined regional data from the
Vascular Quality Initiative (VQI) database to evaluate the impact of smok-
ing on outcomes of revascularization in claudicants in the VQI.
Methods: With consent of the members of the Carolinas Vascular
Quality Group (CVQG) of the VQI, all cases entered in the infrainguinal
(INF) bypass, suprainguinal bypass, and peripheral vascular intervention
modules were reviewed from 2010 to 2012. Univariate analysis was used
to identify demographic and comorbid differences between active and non-
active smokers. Multivariable regression modeling was used to assess pri-
mary outcomes of major adverse limb event (MALE), amputation-free
survival (AFS), limb loss (LL), and death.
Results: We identiﬁed 730 active smokers and 636 nonactive smokers
undergoing revascularization for claudication. Mean follow-up was 247
(214) days. Active smokers were younger and had more chronic obstructive
pulmonary disease, but less diabetes, congestive heart failure, hypertension,
and statin use. Multivariable regression modeling showed no differences in
overall outcomes of MALE, AFS, and death between active and nonactive
smokers when all procedure modules were combined; active smokers were
more likely, however, to suffer limb loss (3% vs 11%; odds ratio [OR],
2.3; 95% conﬁdence interval [CI], 1.0-5.4; P ¼ .05). When we examined
the modules separately, there were no differences in outcomes between
active and nonactive smokers in peripheral vascular intervention (n ¼
1252 limbs) or suprainguinal bypass (n ¼ 122). Compared with nonactivesmokers, active smokers with claudication who received INF bypass had a
much higher odds of MALE (21% vs 11%; OR, 2.8; 95% CI, 1.1-7.4; P
¼ .03) and limb loss (10% vs 1%; OR, 21.0; 95% CI, 1.5-292; P ¼ .02),
but had no difference in death or AFS (Table).
Conclusions: Claudicants who undergo INF bypass while actively
smoking have increased odds of MALE and limb loss compared with non-
active smokers in the CVQG. ORs for limb loss and MALE are signiﬁcantly
higher than that of previously reported patients with claudication treated
with medical management. Before performing INF bypass on claudicants,
aggressive smoking cessation methods should be implemented.Author Disclosures: R. Vallabhaneni: None; C. A. Kalbaugh: None;M.
A. Farber: None; B. H. Tonnessen: None; T. E. Brothers: None; W. A.
Marston: None; J. W. Hallett: None.
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Introduction: The aim of our study was to perform a large-scale
multivariate analysis to identify the demographic, anatomic, or procedural
factors that impact primary iliac stent patency.
Methods: A retrospective record review of iliac stenting from 2011 to
2013 was conducted. Index iliac stenting patients were identiﬁed by Cur-
rent Procedural Terminology codes 37220, 37221, 37222, and 37223. Dif-
ferences in demographic, anatomic, and procedural characteristics were
analyzed by univariate analysis between groups based on primary patency.
Variables that were considered signiﬁcant (P < .05) were brought forward
in the Cox regression multivariate analysis.
Results: A total of 224 patients (53% male) underwent primary iliac
artery stenting, and 319 limbs were analyzed. Average age was 66 years
(range, 38-93 years) and 57% were Caucasian. Indication for procedure
was 64% claudication, 23% rest pain, and 13% ulcer/gangrene. The cohort
included all TransAtlantic Inter-Society Consensus (TASC) classiﬁcations:
50% TASC A, 25% TASC B, 12% TASC C, and 13% TASC D. The treated
anatomic location was isolated external iliac artery (EIA) in 27%, isolated
common iliac artery (CIA) in 55%, and combined CIA/EIA in 18%. Inter-
vention distal to the iliac arteries was performed in 37% of the cohort. There
were no procedural-related mortalities. Kaplan-Meier analysis at 1 and
3 years revealed a primary patency of 86% and 51%, primary assisted patency
of 98% and 89%, and secondary patency of 99% and 90%. For those patients
with critical limb ischemia preprocedurally, limb salvage was 88% at 1 year.
By Kaplan-Meier analysis, primary patency at 1 year was 93% for Caucasian
patients vs 79% for non-Caucasian (P ¼ .001). One-year Kaplan-Meier pri-
mary patency was 76% in patients aged <60 years, 86% in patients aged 60-
70 years, and 97% in patients aged >70 years, with a signiﬁcant difference
among all groups (P < .001). Primary patency was signiﬁcantly different
for those with and without EIA occlusion (P < .001), with 1-year primary
patency by Kaplan-Meier analysis of 71% and 86%, respectively. Primary
patency was also signiﬁcantly different for those with and without aortic oc-
clusion (P ¼ .008), with 1-year patency of 84% and 87%, respectively. The
reentry device differed signiﬁcantly among groups (P ¼ .028), with 1-year
patency rates of 79% for reentry device use and 87% for those who did
not have reentry device. We evaluated ﬁve factors on multivariate analysis,
and three factors were identiﬁed to impact primary patency: Caucasian
race (HR, 0.517; 95% conﬁdence interval [CI], 0.313-0.852; P ¼ .01)
and older age at the time of procedure (HR, 0.945; 95% CI, 0.920-
0.971; P < .001) positively affected patency. EIA occlusion (HR, 2.352;
95% CI, 1.294-4.275; P ¼ .005) negatively affected primary patency. Aortic
occlusion and reentry device were no longer signiﬁcant in our multivariate
model.
JOURNAL OF VASCULAR SURGERY
1716 Abstracts December 2014Conclusions: In our institution’s experience with a large number of
iliac interventions (CIA and EIA), race, age, and EIA occlusion all impacted
primary patency. This study emphasizes the underappreciated effect of pa-
tient demographics and lesion severity on stenting outcomes.
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Introduction: Rupture of an abdominal aortic aneurysm (AAA) is a
usually fatal event best prevented by timely diagnosis and surgical interven-
tion. Evidence is accumulating that women tend to rupture AAAs at smaller
sizes than men, are often at higher risk because of age and comorbidities,
and have poorer outcomes. In the past, women were often excluded from
lower-risk endovascular aortic aneurysm repair (EVAR) because of inade-
quate iliac vascular access. Furthermore, current elective operative recom-
mendations for asymptomatic AAA repair of >5.5 cm do not distinguish
possible differences between men and women regarding the advantages of
earlier treatment with respect to the risk of rupture relative to AAA size.
Methods: All patients evaluated with International Classiﬁcation of
Diseases-9th Revision diagnosis codes for AAAs at a single institution be-
tween 2000 and 2012 were identiﬁed for retrospective analysis under Inves-
tigational Review Board approval.
Results: A total of 3800 patients were identiﬁed with a diagnosis of
AAA. Of these, there were 3686 patients (97%) with nonruptured AAAs
and 114 patients (3%) with ruptured AAAs. The male-to-female ratios for
nonruptured and ruptured AAAs were similar (2.9:1 and 2.5:1, respectively)
as were the percentages of ruptured AAAs for men and women (2.9% and
3.4%, respectively). Also similar were jospital mortality rates for ruptured
AAAs in men (42.0%) and women (42.4%). AAA diameter at the time of
rupture was determined in 75 patients (54 men and 21 women). The mean
ruptured AAA diameter was 7.9 6 1.6 cm (range, 4.5-12.0 cm) for men
and 6.5 6 1.5 cm (range, 3.6-9.0 cm) for women. Of the ruptured AAA pa-
tients, 97.3% were treated with emergency open AAA repair and 2.7% by
emergency EVAR. The percentage of patients with a ruptured AAA
<5.5 cm in diameter was 28.6% for women and only 3.7% for men (Fig).
Conclusions: Although this single-institution experience is small, these
results strongly indicate that AAAs in women tend to rupture at smaller diame-
ters than men. Mortality for elective EVAR has dramatically decreased AAA
operative risk, and the newer low-proﬁle delivery systems have made this tech-
nology routinely available for women. Current recommendations for elective
operative intervention forAAAs shouldbe reconsidered and stratiﬁedbygender.Fig. Percentage rupture with 5.5-cm threshold.
Fig 1. A, Vein graft computed tomography (CT) cross-sectional area vs ul-
trasound (U/S) velocity. B, Vein graft CT stenosis ratio vs U/S velocity ratio.Author Disclosures: A. Skibba: None; J. Evans: None; S. Hopkins:
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Background: Infrainguinal vein graft bypass has 5-year patency rates
between 45 and 80%, and the optimal post-operative approach to graft sur-
veillance is not clear. The current study was designed to evaluate the rela-
tionship between physiologic (duplex scanning) and anatomic (CT scan)
methodologies for assessment of vein graft stenosis and evaluate the rela-
tionship of these observed abnormalities to vein graft failure.
Methods: Fifty-four patients who underwent infrainguinal autogenous
vein graft bypass for disabling claudication or tissue loss at the Malcolm Ran-
dall Veterans Affairs Medical Center in Gainesville, Florida were included in
our study. These patients were followed with concurrent duplex U/S andCT
imaging at intervals of 1 week, 1 month, 6 months, and 12 months postop-
eration. For each of the “zones” within the bypass graft (we divide the leg
into six zones), and U/S peak-systolic velocity and mean CT cross-sectional
area were calculated. Thus, our initial data set consisted of both an U/S ve-
locity measurement and a CT cross-sectional area measurement for each zone
per patient, at each of the four time points for a total of 656 patient*zone*-
time points (Fig 1, A). We also transformed these 656 sets of CT and U/S
data into CT percent stenosis and U/S velocity ratios.
Results: A CT stenosis less than 50% was extremely highly correlated
with success (0% failure), while a velocity ratio > 3.5 was correlated with a
67% failure rate (Fig 1, B; Table). Interestingly, even high degrees of CT
demonstrated stenosis were still more likely to succeed than not, with those
in the >80% group having only a 25% failure rate (Table). Those zones with
moderate graft stenosis, identiﬁed as a duplex-derived velocity ratio in the
2.0 to 3.5 range, tended to improve with time as 78% showed a reduction
in the velocity ratio at the next time interval (Fig 2). Importantly, within this
group only a 12% failure rate was seen, thus demonstrating the relatively
benign nature of this degree of stenosis (Table).
